.png){kind=icon}
.png){kind=icon}
Return
Biosynthesis of Benzohydroxamic Acid in Streptomyces angustmyceticus
.png){kind=icon}
OA
AI
J
P
J
Q
W
DOI：10.1021/acs.jnatprod.6c00526.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Benzohydroxamic acid (BHA) is an important hydroxamate scaffold with potential applications in medicinal chemistry and crop protection, but it has not previously been established as a natural product. Here, we report the discovery and biosynthetic characterization of BHA from Streptomyces angustmyceticus. A conserved TsnB-like gene cassette comprising SaAmOx-AS, SaAmOx, and SaHAT was identified by genome mining, indicating a potential capacity for hydroxamate formation and transfer. BHA was detected as a fermentation product of S. angustmyceticus and structurally confirmed by comparison with an authentic standard, compound purification, and NMR spectroscopic analysis. Benzoic acid was established as the aromatic precursor of BHA through deuterium-labeling experiments with benzaldehyde and cinnamic acid. SaHAT was identified as the key hydroxamate-transfer enzyme that directly converts benzoic acid, rather than benzoyl-CoA, to BHA using glutamyl hydroxamate as the hydroxamate donor in an ATP- and Mg2+-dependent reaction. BHA production was reconstituted in Escherichia coli by heterologous coexpression of SaAmOx-AS, SaAmOx, and SaHAT, confirming that these three enzymes form a minimal biosynthetic module. This work establishes BHA as a microbial natural product and provides a foundation for engineering hydroxamate-containing compounds.
Keywords:
Bacteria
Biosynthesis
Metabolism
Organic acids
Peptides and proteins
Journal
IF:
3.6
Papers:
1.2W
Citations:
2.9W
Organization
Cited Papers